|
Volumn 287, Issue 6, 2002, Pages 719-725
|
Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: A randomized crossover trial
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
SILDENAFIL;
ADULT;
AGED;
ANGINA PECTORIS;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
CROSSOVER PROCEDURE;
DIASTOLIC BLOOD PRESSURE;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DYSPNEA;
ERECTILE DYSFUNCTION;
EXERCISE ELECTROCARDIOGRAPHY;
HEART EJECTION FRACTION;
HEART RATE VARIABILITY;
HEMODYNAMIC MONITORING;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SYSTOLIC BLOOD PRESSURE;
UNITED STATES;
|
EID: 0037070232
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.287.6.719 Document Type: Article |
Times cited : (180)
|
References (37)
|